CD4 and neoplasm: Besides FOXP3+CD4+ Treg cells, other immune cell types, such as NK cells, immunoregulatory APCs, MDSCs [111, 112], and CD8+ regulatory cells [113, 114], may affect tumor progression and directly or indirectly enhance T cell dysfunction.